Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
Marie Jeansson, … , Mark Henkelman, Susan E. Quaggin
Marie Jeansson, … , Mark Henkelman, Susan E. Quaggin
Published May 23, 2011
Citation Information: J Clin Invest. 2011;121(6):2278-2289. https://doi.org/10.1172/JCI46322.
View: Text | PDF
Research Article

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury

  • Text
  • PDF
Abstract

Angiopoietin-1/Tek signaling is a critical regulator of blood vessel development, with conventional knockout of angiopoietin-1 or Tek in mice being embryonically lethal due to vascular defects. In addition, angiopoietin-1 is thought to be required for the stability of mature vessels. Using a Cre-Lox conditional gene targeting approach, we have studied the role of angiopoietin-1 in embryonic and adult vasculature. We report here that angiopoietin-1 is critical for regulating both the number and diameter of developing vessels but is not required for pericyte recruitment. Cardiac-specific knockout of angiopoietin-1 reproduced the phenotype of the conventional knockout, demonstrating that the early vascular abnormalities arise from flow-dependent defects. Strikingly, deletion in the entire embryo after day E13.5 produced no immediate vascular phenotype. However, when combined with injury or microvascular stress, angiopoietin-1 deficiency resulted in profound organ damage, accelerated angiogenesis, and fibrosis. These findings redefine our understanding of the biological roles of angiopoietin-1: it is dispensable in quiescent vessels but has a powerful ability to modulate the vascular response after injury.

Authors

Marie Jeansson, Alexander Gawlik, Gregory Anderson, Chengjin Li, Dontscho Kerjaschki, Mark Henkelman, Susan E. Quaggin

×

Figure 6

Angpt1 protects the glomerular vasculature in diabetic nephropathy.

Options: View larger image (or click on image) Download as PowerPoint
Angpt1 protects the glomerular vasculature in diabetic nephropathy.
(A) ...
(A) Expression of Angpt1, Angpt2, Tgfb1, and Vegfa in whole glomeruli or cell fractions sorted by FACS from diabetic and nondiabetic mice carrying a Kdr-GFP transgene reporter (mean ± SEM). FACS cells from glomeruli are endothelial cells in the GFP-positive fraction (Kdr-GFP +) and mainly podocytes and mesangial cells in the GFP-negative fraction (Kdr-GFP –). (B) Angpt1del/^(E16.5) mice (induced between E16.5 and P0) made diabetic show a significant decrease in survival. (C) After 20 weeks of diabetes, Angpt1del/^(E16.5) mice have a significantly higher urinary albumin/creatinine ratio compared with that of controls and nondiabetic groups. (D) Histology shows an increase in mesangial matrix expansion and sclerosis in diabetic Angpt1del/^(E16.5) mice and diabetic Angpt1del/^(glom) mice compared with that of diabetic controls (H&E, top panel; PAS bottom panel) (scale bar: 50 μm). (E) HbA1C in controls and Angpt1del/^(E16.5) mice is comparable in nondiabetic mice and after 20 weeks of diabetes.

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts